Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis
This study has been completed.
Study NCT00644800   Information provided by Pfizer

First Received on March 20, 2008.   Last Updated on April 7, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
Mania
Delusional Disorder
Acute Exacerbation of Psychosis
Additional conditions recognized in this trial
Bipolar Disorder
Delusions
Mental Disorders
Psychotic Disorders
Schizophrenia, Paranoid
More general conditions related to this trial
Affective Disorders, Psychotic
Behavioral Symptoms
Mood Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Ziprasidone
More general drug interventions related to this trial
Antipsychotic Agents
Central Nervous System Agents
Central Nervous System Depressants
Dopamine Agents
Dopamine Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Antagonists
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services